Type 2 diabetes (T2D) is closely associated with chronic low-grade inflammation and immune-mediated metabolic dysfunction. Increasing evidence highlights ...
Eligibility estimates contract from ~13.3 million with obesity/overweight to ~3.8 million Bridge-eligible Part D enrollees after excluding diabetes, OSA, MASH, and current GLP‑1 users. Modeled ...
Objective To investigate the association between attention-deficit/hyperactivity disorder (ADHD) and cardiometabolic risk profile at the time of type 2 diabetes (T2D) diagnosis and examine ...
Even with all the advances in technology, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, said patients ...
Today, the Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis ...
MiniMed automated insulin delivery and smart MDI systems can now be paired with Instinct and Instinct Go, made by Abbott, the smallest, longest-wear sensors in the company's portfolioNORTHRIDGE ...
Times of San Diego reviewed hundreds of medical records from inside the Otay Mesa detention center.
Experts at ADA 2026 say nutrition guidelines must be personalized, culturally responsive, and built on research that reflects the patients they're meant to serve. In a VESALIUS-CV subgroup analysis, ...
Leapfrog and the American Diabetes Association recognized 37 hospitals for being leaders in caring for people living with diabetes. This is the first national recognition program that honors hospitals ...
A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes ...
Pharmacy Times Continuing Education™ (PTCE) presented new research at the American Diabetes Association (ADA) 2026 Scientific Sessions, held June 5–8 in New Orleans, Louisiana. The ADA Scientific ...
Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or ...